Skip to Content
Søg Menu
Vi dækker

ASH | American Society of Hematology Meeting & Exposition

ASH 2024

Advancing Towards New Treatment Options for AML

  • / Jan Andreasen

Hematology

  • Meet the Experts
  • 2024
Get access

Even Though There Was Little Game-Changing Data, ASH 2024 Provided a Valuable Overview of the Future of Hematology Treatment Across Our Diseases

/ Hæmatologi / Jan Andreasen

Key Findings That Could Transform Multiple Myeloma Treatment

/ Hæmatologi / Jan Andreasen

CLL: Encouraging Results and The Balance Between Deep Response and Side Effects

/ Hæmatologi / Jan Andreasen

Ingen ændringer i behandlingen inden for lymfom efter ASH 2024, men mange vigtige updates

/ Hæmatologi / Tarec Christoffer El-Galaly

ASH 2024: Nyt om AML i dansk perspektiv

/ Hæmatologi / Hans Beier Ommen
Emelie Hamotal Curovic Rotbain

Dansk Aften ASH 2024: Nye fremskridt i behandling af CLL

/ Emelie Hamotal Curovic Rotbain
ASH24CLL Play the Video
Betty Gardie & François Girdon

LBA-2: A New Cause of Hereditary and Acquired Erythrocytosis

/ Betty Gardie / Francois Girodon
ASH24 Play the Video
Bjørn Tore Gjertsen

ASH 2024: AML-forskning tar nye steg med CPX-behandling og meninhemmere

/ Bjørn Tore Gjertsen
ASH24AML Play the Video
Tobias Schmidt Slørdahl

ASH 2024: Siste behandlinger og forskningsfremskritt innen hematologi

/ Tobias S. Slørdahl
ASH24 Play the Video
Fredrik Hellem Schjesvold

ASH 2024: Viktige funn som kan endre behandlingen av myelomatose

/ Fredrik Schjesvold
ASH24Myelomatose Play the Video
Fabian Müller

Treatment of Autoimmune Patients with CD19-CAR T Cells Results in Long-Term Drug-Free Remission or No Progression

/ Fabian Mueller
ASH24CAR-T Play the Video
Alexander Fuglkjær

Machine learning kan reducere unødvendige indlæggelser af kræftpatienter

/ Alexander Fuglkjær
AIASH24Lymfom Play the Video
Muhammad Kashif

Novel Risk Stratification Method for Bone Disease in Multiple Myeloma Patients Minimizes Radiation Exposure and Lowers Economic Burden

/ Muhammad Kashif
AIASH24Myelomatose Play the Video
Ingrid Glimelius

High Infection Burden and Mortality in CLL Patients: A Call for Action

/ Ingrid Glimelius
ASH24CLL Play the Video
Ingrid Glimelius

Zilovertamab Vedotin in Mantle Cell Lymphoma: Promising Results from ASH 2024

/ Ingrid Glimelius
ASH24Lymfom Play the Video
Ingrid Glimelius

High Mortality Rate for Patients with Mantle Cell Lymphoma with a Second Primary Malignancy

/ Ingrid Glimelius
ASH24Lymfom Play the Video

AI Will Play a Significant Role in All Aspects of Hematology in the Future

/ Andrew Srisuwananukorn
AIASH24 Play the Video
Hent flere

ASH 2023

Jason Westin

Potential for Targeted and Immune-Facing Therapies for Patients with CNS Lymphoma

/ Jason Westin
ASH23Lymfom Play the Video
Jad Othman

MRD Status in NPM1 Mutated AML Should Be a Part of the Selection of Patients for Transplant in First Remission

/ Jad Othman
ASH23AML Play the Video
Jason Westin

Chemotherapy Might Not Be Needed in Frontline Treatment of Patients with Large B-Cell Lymphoma

/ Jason Westin
ASH23B-celle lymfom Play the Video
Eva Birgitte Leinøe

Undiagnosed and Unrecognized Patients with a High Bleeding Score

/ Eva Birgitte Leinøe
ASH23 Play the Video
Pieter Sonneveld

A Potential New Standard of Care for Transplant-Eligible Patients with Multiple Myeloma

/ Pieter Sonneveld
ASH23Myelomatose Play the Video

ASH 2023: The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated CLL

/ BestPractice Nordic
ASH23CLL
Jeff P. Sharman

No Increased Risk of Ventricular Arrhythmias and Sudden Death with Acalabrutinib

/ Jeff P. Sharman
ASH23CLL Play the Video
Gabriel Brisou

Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B-Cell Lymphoma

/ Gabriel Brisou
ASH23B-celle lymfom Play the Video
Hent flere

ASH 2022

Christine Ryan

Updated results on AVO therapeutic triplet regimen in untreated patients with CLL

/ Christine Ryan
ASH22CLL Play the Video
Ryan Jacobs

CLL – The impact of using ibrutinib as front-line treatment

/ Ryan Jacobs
ASH22CLL Play the Video
Eunice Wang

Treatment Options for FLT3 mutant acute myeloid leukemia

/ Eunice Wang
ASH22AML Play the Video
Roch Houot

Axicabtagene ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients

/ Roch Houot
ASH22Lymfom Play the Video
Régis Peffault De Latour

Superior efficacy of Iptacopan in PNH patients

/ Régis Peffault De Latour
ASH22 Play the Video
Carsten Utoft Niemann

CLL – Update fra ASH 2022

/ Carsten Utoft Niemann
ASH22CLL Play the Video
Signe Modvig

New potential key pathway in patients with ALL

/ Signe Modvig
ASH22ALL Play the Video
Jennifer R. Brown

Significant longer PFS among patients who received zanubrutinib vs ibrutinib

/ Jennifer R. Brown
ASH22CLL Play the Video
Hent flere

ASH 2021

Matthew Davids

Several interesting combinations of therapies with Calquence for patients with CLL

/ Matthew S. Davids
ASH22CLL Play the Video
Jad Othman

UK NCRI AML19 Trial – Liposomal daunorubicin and cytarabine had a significant survival benefit

/ Jad Othman
ASH22AML Play the Video

Venetoclax plus obinutuzumab er den mest omkostningseffektive behandling af CLL uden del17p/TP53-mutationer

/ Matilde Slot
ASH22CLL Play the Video
Ali Bazarbachi

AML patients with FLT3-ITD and wild-type NPM1 has a significant improvement of LFS, OS and GRFS

/ Ali Bazarbachi
ASH22AML Play the Video

AML-highlights fra ASH22 – i dansk perspektiv

/ Hans Beier Ommen
ASH22AML Play the Video
Anand P. Jillella

Dramatic improvement in 1-year survival for patients with acute promyelocytic leukemia

/ Anand P. Jillella
ASH22Leukæmi Play the Video
Paul Richardson

New combination shows promising efficacy in patients with triple-class refractory R/R multiple myeloma

/ Paul G. Richardson
ASH22Myelomatose Play the Video
Sudipto Mukherjee

Lower-risk myelodysplastic syndromes treated with Reblozyl, luspatercept – Real-world outcomes

/ Sudipto Mukherjee
ASH22 Play the Video
Hent flere
Back to top